Chronic Kidney Disease (CKD)

AKI Subphenotypes Carry Different Risks for Major Adverse Kidney Events

Publish Date June 1, 2023

Identification of AKI subphenotypes and their pathogenesis may lead to individualized therapies to prevent adverse kidney events.

Benzbromarone vs Allopurinol for Hyperuricemia May Reduce CKD Risk

Publish Date June 1, 2023

Benzbromarone, a urate-lowering drug, appeared effective among patients with high serum uric acid levels who had no evidence of gout flares.

Febuxostat Reduces Contrast-Induced Acute Kidney Injury in Stage 3 CKD

Publish Date May 31, 2023

Patients with stage 3 chronic kidney disease are at increased risk for contrast-induced acute kidney injury.

Inequalities in Human Resources for Health Linked to Mortality

Publish Date May 30, 2023

Negative association seen between total human resources for health level and all-cause mortality

Sodium Thiosulfate Does Not Improve Calciphylaxis in Chronic Kidney Disease

Publish Date May 22, 2023

Currently, there is no approved therapy for calciphylaxis.

Health Care Workers Lack Advance Care Planning Training for CKD Patients

Publish Date May 19, 2023

Less than half of providers in Denmark say advance care planning is performed well at their workplace

Dapagliflozin Reduces Serum Uric Acid in Advanced Chronic Kidney Disease

Publish Date May 16, 2023

The effects of SGLT2 inhibitors on serum uric acid do not appear to depend on kidney function or diabetes status.

The Changing Treatment Paradigm for IgAN

Publish Date May 12, 2023

Clinicians have a growing number of options for treating immunoglobulin A nephropathy.

Rates of Hyperkalemia, Other Adverse Events Increase as CKD Progresses

Publish Date May 11, 2023

Adverse events rates have been rising over time among patients receiving dialysis, investigators reported.

Uric Acid Thresholds That Predict Risk of Kidney Failure, Death Identified

Publish Date May 11, 2023

The relationship between current serum uric acid levels and death followed a U-shape.